ArticleDermatology and therapy2022

Cost-Effectiveness Analysis Update of the Adjuvanted Recombinant Zoster Vaccine in Japanese Older Adults.

Lida Teng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.